| NDC Code | 52244-404-10 |
|---|
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (52244-404-10) |
|---|
| Product NDC | 52244-404 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Semprex |
|---|
| Proprietary Name Suffix | D |
|---|
| Non-Proprietary Name | Acrivastine And Pseudoephedrine Hydrochloride |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20120126 |
|---|
| End Marketing Date | 20201231 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA019806 |
|---|
| Manufacturer | Endo Pharmaceuticals Inc. |
|---|
| Substance Name | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
|---|
| Strength | 8; 60 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
|---|